$BBNX stock has now fallen 36% today, according to our price data from Polygon. There has been approximately $111,693,548 of trading volume.
It has been the 759th most-searched ticker on Quiver Quantitative over the last day, out of 10,281 total tickers searched.
Here is what we see in our data on $BBNX (you can track the company live on Quiver's $BBNX stock page):
$BBNX Insider Trading Activity
$BBNX insiders have traded $BBNX stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $BBNX stock by insiders over the last 6 months:
- STEPHEN FEIDER (Chief Financial Officer) has made 0 purchases and 11 sales selling 62,889 shares for an estimated $1,461,508.
- MARK HOPMAN (Chief Commercial Officer) has made 0 purchases and 4 sales selling 35,235 shares for an estimated $655,209.
- MIKE MENSINGER (Chief Product Officer) has made 0 purchases and 5 sales selling 12,152 shares for an estimated $348,897.
- SEAN SAINT (President & CEO) has made 0 purchases and 2 sales selling 6,637 shares for an estimated $159,524.
- MARIA PALASIS has made 0 purchases and 4 sales selling 2,812 shares for an estimated $79,386.
- ADAM LEZACK has made 0 purchases and 4 sales selling 2,812 shares for an estimated $79,322.
- STEVEN JON RUSSELL (Chief Medical Officer) sold 1,015 shares for an estimated $19,146
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BBNX Hedge Fund Activity
We have seen 83 institutional investors add shares of $BBNX stock to their portfolio, and 33 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 1,922,972 shares (+224.0%) to their portfolio in Q3 2025, for an estimated $38,209,453
- VANGUARD GROUP INC added 1,509,217 shares (+213.5%) to their portfolio in Q3 2025, for an estimated $29,988,141
- PERCEPTIVE ADVISORS LLC removed 1,315,664 shares (-82.6%) from their portfolio in Q3 2025, for an estimated $26,142,243
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 948,965 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $18,855,934
- ARROWMARK COLORADO HOLDINGS LLC removed 925,363 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $18,386,962
- MORGAN STANLEY added 812,218 shares (+27.5%) to their portfolio in Q3 2025, for an estimated $16,138,771
- HOLOCENE ADVISORS, LP removed 770,851 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $15,316,809
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BBNX Analyst Ratings
Wall Street analysts have issued reports on $BBNX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 10/29/2025
- Goldman Sachs issued a "Buy" rating on 10/29/2025
- Stifel issued a "Buy" rating on 10/29/2025
- Truist Securities issued a "Buy" rating on 09/22/2025
To track analyst ratings and price targets for $BBNX, check out Quiver Quantitative's $BBNX forecast page.
$BBNX Price Targets
Multiple analysts have issued price targets for $BBNX recently. We have seen 7 analysts offer price targets for $BBNX in the last 6 months, with a median target of $33.0.
Here are some recent targets:
- Frank Takkinen from Lake Street set a target price of $40.0 on 01/09/2026
- Travis Steed from B of A Securities set a target price of $33.0 on 01/05/2026
- Richard Newitter from Truist Securities set a target price of $37.0 on 12/18/2025
- David Roman from Goldman Sachs set a target price of $33.0 on 10/29/2025
- Jonathan Block from Stifel set a target price of $31.0 on 10/29/2025
- Matt O'Brien from Piper Sandler set a target price of $32.0 on 10/29/2025
- Jeff Johnson from Baird set a target price of $17.0 on 07/30/2025
You can track data on $BBNX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
